Details

Autor(en) / Beteiligte

• Silva, Johnatas Dutra
• de Oliveira, Gisele Pena
• Samary, Cynthia dos Santos
• Araujo, Carla Cristina
• Padilha, Gisele de Araujo
• e Silva Filho, Fernando Costa
• da Silva, Rosilane Taveira
• Einicker-Lamas, Marcelo
• Morales, Marcelo Marcos
• Capelozzi, Vera Luiza
• da Silva, Vanessa Martins
• Lima, Lídia Moreira
• Barreiro, Eliezer Jesus
• Diaz, Bruno Lourenço
• Pelosi, Paolo
• Silva, Pedro Leme
• Garcia, Cristiane Souza Nascimento Baez
• Rocco, Patricia Rieken Macedo

Titel

Respiratory and Systemic Effects of LASSBio596 Plus Surfactant in Experimental Acute Respiratory Distress Syndrome

Ist Teil von

• Cellular physiology and biochemistry, 2016-01, Vol.38 (2), p.821-835

Ort / Verlag

Basel, Switzerland: Cell Physiol Biochem Press GmbH & Co KG

Erscheinungsjahr

2016

Quelle

MEDLINE

Beschreibungen/Notizen

• Background/Aims: Exogenous surfactant has been proposed as adjunctive therapy for acute respiratory distress syndrome (ARDS), but it is inactivated by different factors present in the alveolar space. We hypothesized that co-administration of LASSBio596, a molecule with significant anti-inflammatory properties, and exogenous surfactant could reduce lung inflammation, thus enabling the surfactant to reduce edema and improve lung function, in experimental ARDS. Methods: ARDS was induced by cecal ligation and puncture surgery in BALB/c mice. A sham-operated group was used as control (CTRL). After surgery (6 hours), CTRL and ARDS animals were assigned to receive: (1) sterile saline solution; (2) LASSBio596; (3) exogenous surfactant or (4) LASSBio596 plus exogenous surfactant (n = 22/group). Results: Regardless of exogenous surfactant administration, LASSBio596 improved survival rate and reduced collagen fiber content, total number of cells and neutrophils in PLF and blood, cell apoptosis, protein content in BALF, and urea and creatinine levels. LASSBio596 plus surfactant yielded all of the aforementioned beneficial effects, as well as increased BALF lipid content and reduced surface tension. Conclusion: LASSBio596 exhibited major anti-inflammatory and anti-fibrogenic effects in experimental sepsis-induced ARDS. Its association with surfactant may provide further advantages, potentially by reducing surface tension.